IMM Immupharma Plc

RNS Number:5966B
Immupharma PLC
06 August 2007


For Immediate Release                                              6 August 2007


                                Grant of Options


ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug
discovery and development company, announces the granting of share options to
its Directors. The Company has adopted a HM Revenue & Customs approved share
ownership plan (CSOP) and an unapproved share option scheme.


The amount of options granted are summarised in the following table:

Director                             Options Granted

Richard Warr                         140,000
Robert Zimmer                        150,000
Dimitri Dimitriou                    140,000
Franco di Muzio                      100,000
Ajay Agrawal                         100,000


The option price was set at 76.8p per share. The options are exercisable after 3
years and up to 10 years from being granted.


For further information, please contact:

ImmuPharma PLC
Dimitri Dimitriou, Chief Executive Officer                    + 44 020 7152 4080
Richard Warr, Chairman
Dr Robert Zimmer, President & Chief Scientific Officer        +33 389 32 76 50


Buchanan Communications                                       +44 20 7466 5000
Lisa Baderoon
Rebecca Skye Dietrich


Teather & Greenwood (NOMAD & Broker)                          +44 020 7426 9000
Thilo Hoffmann
Jeff Keating







                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCPFMITMMJMBRR

Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From Jul 2023 to Jul 2024